Former CEO (3) · Actinium Pharmaceuticals, Inc. (ATNM)

Kaushik Dave

FY2017 is the first fiscal year CompBrief holds for Kaushik Dave as a named executive officer of Actinium Pharmaceuticals; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2017

$932,708

Salary $577,942Stock awards $0Bonus $110,000

1st of 6 named executive officers at Actinium Pharmaceuticals by FY2017 total.

6 named officers on file for Actinium Pharmaceuticals, FY2017

Kaushik Dave’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Actinium Pharmaceuticals’s whole pay program stands against its peers

  • Actinium Pharmaceuticals’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ATNM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed November 25, 2019 (DEF 14A).

Free

Get Kaushik Dave’s full pay file as a PDF — free

More than this page: up to 10 years of Kaushik’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Kaushik Dave compensation by year

Actinium Pharmaceuticals Summary Compensation Table · the one fiscal year held
In US dollars, as Actinium Pharmaceuticals reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017
Salary$577,942
Bonus$110,000
Stock awards$0
Option awards$244,766
Non-equity incentive$0
Pension and deferred compensation$0
All other$0
Total$932,708

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Actinium Pharmaceuticals, Inc. DEF 14A filed November 25, 2019, accession 0001213900-19-024628, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Actinium Pharmaceuticals, Inc. filed document, accession 0001213900-19-024628. Every figure is read from that document and cited to the page and table it appears in. Filed November 25, 2019.

Actinium Pharmaceuticals’s named executive officers, FY2017

as the company reported each
Named executive officerRoleFY2017 total
Kaushik Dave · this pageFormer CEO (3)$932,708
Mark BergerChief Medical Officer$578,445
Dragan CicicFormer COO (4)$507,555
Steve O’LoughlinChief Financial Officer$383,059
Nitya RayFormer Executive Vice President (5)$376,169
Sandesh SethChairman and Chief Executive Officer$306,250

The full Actinium Pharmaceuticals compensation record

free company brief

This page is one person within Actinium Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Actinium Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Kaushik Dave's compensation dossier · One-time report. No refunds.